Results 251 to 260 of about 6,936,275 (302)

Human cytomegalovirus UL18 prevents priming of MHC-E- and MHC-II-restricted CD8<sup>+</sup> T cells. [PDF]

open access: yesSci Immunol
Malouli D   +20 more
europepmc   +1 more source

Targeting PCSK9 to upregulate MHC-II on the surface of tumor cells in tumor immunotherapy. [PDF]

open access: yesBMC Cancer
Wang H   +8 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Antiallergic effects of technologically processed antibodies to MHC II

Bulletin of Experimental Biology and Medicine, 2023
The risk of developing anaphylactic reactions to medications introduces additional difficulties for effective pharmacotherapy. Using a model of systemic anaphylaxis in mice, we showed that preventive administration of a preparation containing technologically processed antibodies (TPA) to MHC II induces an anti-anaphylactic effect comparable to that of ...
N V, Petrova   +5 more
openaire   +2 more sources

Quantifying Significance of MHC II Residues

IEEE/ACM Transactions on Computational Biology and Bioinformatics, 2014
The major histocompatibility complex (MHC), a cell-surface protein mediating immune recognition, plays important roles in the immune response system of all higher vertebrates. MHC molecules are highly polymorphic and they are grouped into serotypes according to the specificity of the response.
Ying Fan   +4 more
openaire   +3 more sources

MHC-II Ubiquitination

2012
Ubiquitinated protein detection is often troublesome since in most cases this modification reduces the half-life of targeted proteins, inducing their degradation. Furthermore, ubiquitination is reversible thanks to the action of highly specific deubiquitinases present in all eukaryotic cells.
Aude, De Gassart   +2 more
openaire   +2 more sources

Control of MHC II antigen presentation by ubiquitination

Current Opinion in Immunology, 2013
MHC II antigen presentation is a critical pathway involved in the activation of the adaptive immune system. Tight regulatory controls are necessary to ensure appropriate MHC II antigen presentation. One mechanism for regulating this pathway is ubiquitination.
Jessica M, Moffat   +2 more
openaire   +2 more sources

Epigenetic regulation of MHC-II and CIITA genes

Trends in Immunology, 2006
This review describes recent advances in understanding how epigenetic events control MHC-class-II-family (MHC-II) gene expression. To address this issue, two phases of gene transcription have to be considered. First, the control of MHC-II by chromatin-modifying events such as histone acetylation, methylation, deacetylation, ubiquitination and the ...
Kenneth L, Wright, Jenny P-Y, Ting
openaire   +2 more sources

Home - About - Disclaimer - Privacy